Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
2008 · PubMed · 449 citations
https://doi.org/10.1001/jama.299.15.1800
Brown University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
2.6K
Citations
24
h-index
50
i10-index
David Egilman is an academic researcher from Brown University. The author has contributed to research in topics: Occupational and environmental lung diseases & Pharmaceutical industry and healthcare & Occupational exposure and asthma. The author has an h-index of 24, co-authored 121 publications.
ORCID: 0000-0003-0280-163Xhttps://doi.org/10.1001/jama.299.15.1800
https://doi.org/10.1179/2049396714y.0000000103
Click to start Chat